89 related articles for article (PubMed ID: 15110847)
21. Potential therapeutic targets for neurokinin-1 receptor antagonists.
Duffy RA
Expert Opin Emerg Drugs; 2004 May; 9(1):9-21. PubMed ID: 15155133
[TBL] [Abstract][Full Text] [Related]
22. [Synthesis of new 7, 8 and 9-membered heterocyclic compounds containing oxygen and nitrogen as heteroatoms. III. Synthesis of new hexahydro-1,5-oxazocine derivatives with potential pharmacological activity].
Glinka R; Kotelko B
Acta Pol Pharm; 1976; 33(1):39-48. PubMed ID: 1266642
[No Abstract] [Full Text] [Related]
23. MEN15596, a novel nonpeptide tachykinin NK2 receptor antagonist.
Cialdai C; Tramontana M; Patacchini R; Lecci A; Catalani C; Catalioto RM; Meini S; Valenti C; Altamura M; Giuliani S; Maggi CA
Eur J Pharmacol; 2006 Nov; 549(1-3):140-8. PubMed ID: 16979621
[TBL] [Abstract][Full Text] [Related]
24. Synthesis and antimicrobial activities of oxazepine and oxazocine derivatives.
Tang J; Jiang YL; Wang BX; Shen YM
Z Naturforsch C J Biosci; 2014; 69(7-8):283-90. PubMed ID: 25265848
[TBL] [Abstract][Full Text] [Related]
25. Discovery process and pharmacological characterization of 2-(S)-(4-fluoro-2-methylphenyl)piperazine-1-carboxylic acid [1-(R)-(3,5-bis-trifluoromethylphenyl)ethyl]methylamide (vestipitant) as a potent, selective, and orally active NK1 receptor antagonist.
Di Fabio R; Griffante C; Alvaro G; Pentassuglia G; Pizzi DA; Donati D; Rossi T; Guercio G; Mattioli M; Cimarosti Z; Marchioro C; Provera S; Zonzini L; Montanari D; Melotto S; Gerrard PA; Trist DG; Ratti E; Corsi M
J Med Chem; 2009 May; 52(10):3238-47. PubMed ID: 19388677
[TBL] [Abstract][Full Text] [Related]
26. Neurokinin 1 receptor antagonists--current prospects.
Alvaro G; Di Fabio R
Curr Opin Drug Discov Devel; 2007 Sep; 10(5):613-21. PubMed ID: 17786860
[TBL] [Abstract][Full Text] [Related]
27. Molecular cloning, mutations and effects of NK1 receptor antagonists reveal the human-like pharmacology of gerbil NK1 receptors.
Engberg S; Ahlstedt I; Leffler A; Lindström E; Kristensson E; Svensson A; Påhlman I; Johansson A; Drmota T; von Mentzer B
Biochem Pharmacol; 2007 Jan; 73(2):259-69. PubMed ID: 17097619
[TBL] [Abstract][Full Text] [Related]
28. Senktide-induced gerbil foot tapping behaviour is blocked by selective tachykinin NK1 and NK3 receptor antagonists.
Sundqvist M; Kristensson E; Adolfsson R; Leffler A; Ahlstedt I; Engberg S; Drmota T; Sigfridsson K; Jussila R; de Verdier J; Novén A; Johansson A; Påhlman I; von Mentzer B; Lindström E
Eur J Pharmacol; 2007 Dec; 577(1-3):78-86. PubMed ID: 17920583
[TBL] [Abstract][Full Text] [Related]
29. Ava[L-Pro9,N-MeLeu10] substance P(7-11) (GR 73632) and Sar9, Met(O2)11 increase distention-induced peristalsis through activation of neurokinin-1 receptors on smooth muscle and interstitial cells of cajal.
Nieuwmeyer F; Ye J; Huizinga JD
J Pharmacol Exp Ther; 2006 Apr; 317(1):439-45. PubMed ID: 16330493
[TBL] [Abstract][Full Text] [Related]
30. Neurokinin receptor modulation of respiratory activity in the rabbit.
Bongianni F; Mutolo D; Cinelli E; Pantaleo T
Eur J Neurosci; 2008 Jun; 27(12):3233-43. PubMed ID: 18554294
[TBL] [Abstract][Full Text] [Related]
31. 1H NMR study of the conformation and absolute stereochemistry of two spirocyclic NK-1 antagonists.
Herbert RH; Gerhard U; Mortishire-Smith RJ; Thomas SR; Hollingworth G
Magn Reson Chem; 2005 Aug; 43(8):658-61. PubMed ID: 15924294
[TBL] [Abstract][Full Text] [Related]
32. Tryptophan-derived NK1 antagonists: conformationally constrained heterocyclic bioisosteres of the ester linkage.
Lewis RT; Macleod AM; Merchant KJ; Kelleher F; Sanderson I; Herbert RH; Cascieri MA; Sadowski S; Ball RG; Hoogsteen K
J Med Chem; 1995 Mar; 38(6):923-33. PubMed ID: 7699709
[TBL] [Abstract][Full Text] [Related]
33. The effect of neurokinin1 receptor blockade on territorial aggression and in a model of violent aggression.
Halasz J; Toth M; Mikics E; Hrabovszky E; Barsy B; Barsvari B; Haller J
Biol Psychiatry; 2008 Feb; 63(3):271-8. PubMed ID: 17678879
[TBL] [Abstract][Full Text] [Related]
34. Design and synthesis of a novel, achiral class of highly potent and selective, orally active neurokinin-1 receptor antagonists.
Hoffmann T; Bös M; Stadler H; Schnider P; Hunkeler W; Godel T; Galley G; Ballard TM; Higgins GA; Poli SM; Sleight AJ
Bioorg Med Chem Lett; 2006 Mar; 16(5):1362-5. PubMed ID: 16332435
[TBL] [Abstract][Full Text] [Related]
35. Tachykinins and tachykinin receptors in the gut, with special reference to NK2 receptors in human.
Lecci A; Capriati A; Altamura M; Maggi CA
Auton Neurosci; 2006 Jun; 126-127():232-49. PubMed ID: 16616700
[TBL] [Abstract][Full Text] [Related]
36. Neurokinin-1 receptors modulate the excitability of expiratory neurons in the ventral respiratory group.
Fong AY; Potts JT
J Neurophysiol; 2008 Feb; 99(2):900-14. PubMed ID: 18057111
[TBL] [Abstract][Full Text] [Related]
37. Investigations of anthelminthic activity and synthesis of new derivatives of perhydroazepine, perhydro-1,4-diazepine, perhydro-1,4-oxazepine and perhydro-1,5-oxazocine.
Glinka R; Grzywacz M; Kotełko B; Majchrzak M; Malinowski H; Mikołajewska H; Mikiciukolasik E; Szkukliński J
Pol J Pharmacol Pharm; 1980; 32(5):773-7. PubMed ID: 7196575
[TBL] [Abstract][Full Text] [Related]
38. The NK1 receptor antagonist NKP608 lacks anxiolytic-like activity in Swiss-Webster mice exposed to the elevated plus-maze.
Rodgers RJ; Gentsch C; Hoyer D; Bryant E; Green AJ; Kolokotroni KZ; Martin JL
Behav Brain Res; 2004 Sep; 154(1):183-92. PubMed ID: 15302124
[TBL] [Abstract][Full Text] [Related]
39. The neurokinin-1 antagonist activity of maropitant, an antiemetic drug for dogs, in a gerbil model.
de la Puente-Redondo V; Tingley FD; Schneider RP; Hickman MA
J Vet Pharmacol Ther; 2007 Aug; 30(4):281-7. PubMed ID: 17610400
[TBL] [Abstract][Full Text] [Related]
40. TRPV1 gene knockout impairs postischemic recovery in isolated perfused heart in mice.
Wang L; Wang DH
Circulation; 2005 Dec; 112(23):3617-23. PubMed ID: 16314376
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
